Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Best Practice & Research. Clinical Rheumatology|February 5, 2010
Targeting subchondral bone for treating osteoarthritis: what is the evidence?Steeve Kwan Tat, Daniel Lajeunesse, Jean-Pierre Pelletier, et al.
Cytokine & Growth Factor Reviews|January 30, 2004
IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiologySteeve Kwan Tat, Marc Padrines, Sandrine Théoleyre, et al.
Cytokine & Growth Factor Reviews|November 25, 2004
The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodelingSandrine Theoleyre, Yohann Wittrant, Steeve Kwan Tat, et al.
Bone|June 25, 2011
Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblastsSteeve Kwan Tat, Jean-Pierre Pelletier, François Mineau, et al.
The Journal of Rheumatology|January 30, 2010
Variable effects of 3 different chondroitin sulfate compounds on human osteoarthritic cartilage/chondrocytes: relevance of purity and production processSteeve Kwan Tat, Jean-Pierre Pelletier, François Mineau, et al.
The Keio Journal of Medicine|April 29, 2009
New perspective in osteoarthritis: the OPG and RANKL system as a potential therapeutic target?Steeve Kwan Tat, Jean-Pierre Pelletier, Carmen Ruiz Velasco, et al.
The Journal of Rheumatology|February 3, 2011
Proteinase-activated receptor-2 gene disruption limits the effect of osteoarthritis on cartilage in mice: a novel target in joint degradationNathalie Amiable, Johanne Martel-Pelletier, Bertrand Lussier, et al.
Arthritis Research & Therapy|August 12, 2009
Treatment with ephrin B2 positively impacts the abnormal metabolism of human osteoarthritic chondrocytesSteeve Kwan Tat, Jean-Pierre Pelletier, Nathalie Amiable, et al.
Pageof 2